Zinc, Copper, and Manganese Supplementations in Rheumatic Disease: A Narrative Review.

IF 2.1 Q4 Medicine
Mediterranean Journal of Rheumatology Pub Date : 2025-08-26 eCollection Date: 2025-09-01 DOI:10.31138/mjr.270325.amr
Jozélio Freire de Carvalho, Ana Tereza Amoedo Martinez
{"title":"Zinc, Copper, and Manganese Supplementations in Rheumatic Disease: A Narrative Review.","authors":"Jozélio Freire de Carvalho, Ana Tereza Amoedo Martinez","doi":"10.31138/mjr.270325.amr","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Trace elements, including zinc (Zn), copper (Cu), and manganese (Mn), play crucial roles in various biological functions, particularly in oxidative stress regulation and immune response. Their potential involvement in rheumatic diseases has been suggested, with evidence indicating altered levels of these elements in conditions such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). However, the efficacy of supplementation remains unclear.</p><p><strong>Objective: </strong>This narrative review aims to evaluate the available evidence on Zn, Cu, and Mn supplementation in patients with rheumatic diseases.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted in PubMed, Scielo, and LILACS databases for studies published from 1965 to April 2024. The search followed PRISMA guidelines and included randomised controlled trials (RCTs) and observational studies investigating Zn, Cu, or Mn supplementation in rheumatic diseases.</p><p><strong>Results: </strong>A total of four studies met the inclusion criteria, focusing on Zn and Cu supplementation. No studies on Mn supplementation were identified. Among the included studies, two evaluated Zn supplementation in RA and Behçet's disease, while two assessed Cu supplementation in RA and SLE. The mean participant age ranged from 35 to 54.3 years, with female predominance (28% to 89%). Follow-up durations varied from 4 to 24 weeks. Zn supplementation demonstrated clinical and immunological benefits, including reduced disease activity in Behçet's disease and improved inflammatory markers in RA. Conversely, Cu supplementation did not show significant therapeutic effects. Reported side effects were mild and primarily gastrointestinal, occurring in 4% to 33% of participants.</p><p><strong>Conclusion: </strong>Zn supplementation appears beneficial in certain rheumatic diseases, particularly in RA and Behçet's disease, while Cu supplementation lacks significant therapeutic effects. Further high-quality RCTs are needed to establish definitive recommendations.</p>","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"36 3","pages":"479-481"},"PeriodicalIF":2.1000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536746/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mediterranean Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31138/mjr.270325.amr","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Trace elements, including zinc (Zn), copper (Cu), and manganese (Mn), play crucial roles in various biological functions, particularly in oxidative stress regulation and immune response. Their potential involvement in rheumatic diseases has been suggested, with evidence indicating altered levels of these elements in conditions such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). However, the efficacy of supplementation remains unclear.

Objective: This narrative review aims to evaluate the available evidence on Zn, Cu, and Mn supplementation in patients with rheumatic diseases.

Methods: A comprehensive literature search was conducted in PubMed, Scielo, and LILACS databases for studies published from 1965 to April 2024. The search followed PRISMA guidelines and included randomised controlled trials (RCTs) and observational studies investigating Zn, Cu, or Mn supplementation in rheumatic diseases.

Results: A total of four studies met the inclusion criteria, focusing on Zn and Cu supplementation. No studies on Mn supplementation were identified. Among the included studies, two evaluated Zn supplementation in RA and Behçet's disease, while two assessed Cu supplementation in RA and SLE. The mean participant age ranged from 35 to 54.3 years, with female predominance (28% to 89%). Follow-up durations varied from 4 to 24 weeks. Zn supplementation demonstrated clinical and immunological benefits, including reduced disease activity in Behçet's disease and improved inflammatory markers in RA. Conversely, Cu supplementation did not show significant therapeutic effects. Reported side effects were mild and primarily gastrointestinal, occurring in 4% to 33% of participants.

Conclusion: Zn supplementation appears beneficial in certain rheumatic diseases, particularly in RA and Behçet's disease, while Cu supplementation lacks significant therapeutic effects. Further high-quality RCTs are needed to establish definitive recommendations.

锌、铜和锰在风湿病中的补充:一个叙述性的回顾。
背景:锌(Zn)、铜(Cu)和锰(Mn)等微量元素在多种生物功能中发挥着重要作用,特别是在氧化应激调节和免疫应答中。它们可能与风湿性疾病有关,有证据表明,在类风湿性关节炎(RA)和系统性红斑狼疮(SLE)等疾病中,这些元素的水平发生了改变。然而,补充剂的功效尚不清楚。目的:本综述旨在评价风湿性疾病患者补充锌、铜和锰的现有证据。方法:在PubMed、Scielo和LILACS数据库中检索1965年至2024年4月发表的文献。该研究遵循PRISMA指南,纳入随机对照试验(rct)和观察性研究,调查锌、铜或锰补充剂在风湿病中的作用。结果:共有4项研究符合纳入标准,重点关注锌和铜的补充。没有关于锰补充的研究被确认。在纳入的研究中,两项研究评估了RA和behet病的锌补充,两项研究评估了RA和SLE的Cu补充。参与者的平均年龄为35岁至54.3岁,女性居多(28%至89%)。随访时间从4到24周不等。锌补充剂显示出临床和免疫益处,包括降低behet病的疾病活动性和改善RA的炎症标志物。相反,铜补充剂没有显示出显著的治疗效果。报告的副作用是轻微的,主要是胃肠道的,发生在4%到33%的参与者中。结论:补锌对某些风湿病有一定的治疗作用,尤其是对类风湿关节炎(RA)和behet病(behet’s disease),而补锌缺乏明显的治疗效果。需要进一步的高质量随机对照试验来建立明确的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
42
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书